Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Clinical trial NCT00101335 · COMPLETED

Trial details

NCT number: NCT00101335
Sponsor: Fox Chase Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Precancerous Condition

Start date: 2003-11-01
Primary completion: 2005-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.